Show simple item record

dc.contributor.authorPhillips, Elizabeth H
dc.contributor.authorIllidge, Timothy M
dc.date.accessioned2020-08-10T08:09:15Z
dc.date.available2020-08-10T08:09:15Z
dc.date.issued2020en
dc.identifier.citationPhillips EH, Illidge TM. Is it time to rethink checkpoint blockade therapy in non-Hodgkin lymphoma? Br J Haematol. 2020.en
dc.identifier.pmid32557549en
dc.identifier.doi10.1111/bjh.16854en
dc.identifier.urihttp://hdl.handle.net/10541/623064
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1111/bjh.16854en
dc.titleIs it time to rethink checkpoint blockade therapy in non-Hodgkin lymphoma?en
dc.typeArticleen
dc.contributor.departmentDivision of Cancer Sciences, University of Manchester, Manchester, UK.en
dc.identifier.journalBritish Journal of Haematologyen
dc.description.noteen]
refterms.dateFOA2020-08-12T09:30:31Z


Files in this item

Thumbnail
Name:
bjh is it time.pdf
Size:
69.03Kb
Format:
PDF
Description:
UNPAYWALL

This item appears in the following Collection(s)

Show simple item record